FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Keytruda OKd for Head-Neck Cancer Pre/Post-Surgery

[ Price : $8.95]

FDA approves Mercks Keytruda (pembrolizumab) as the first anti‑PD‑1 therapy that can be given both before and after su...

FDA Clinical Hold on Pulmonary Fibrosis Drug

[ Price : $8.95]

FDA places a clinical hold on a Rein Therapeutics Phase 2 (RENEW) trial of LTI-03 due to agency requests for additional non-clinic...

Guide on ANDA Pre-Submission Facility Correspondence

[ Price : $8.95]

FDA posts a final guidance entitled ANDAs: Pre-Submission Facility Correspondence (PFC) Related to Prioritized Generic Drug Submis...

Senators Introduce Bill to Ban DTC Drug Advertising

[ Price : $8.95]

Senators Bernie Sanders (I-VT) and Angus King (I-ME) introduce legislation that would ban direct-to-consumer drug advertising.

Oncologic Panel to Review Multiple Myeloma BLA

[ Price : $8.95]

FDA schedules a 7/17 meeting of its Oncologic Drugs Advisory Committee to review and vote on a GSK BLA for Blenrep (belantamab maf...

Medtronic Newport Ventilator Recall Class 1

[ Price : $8.95]

FDA says a Medtronic recall of specified Newport ventilators is Class 1.

Questions Raised on New ACIP Members

[ Price : $8.95]

The Associated Press reports that questions are being raised about some new members appointed to the CDC Advisory Committee on Imm...

Capricor Gets Form-483 After BLA Facility Inspection

[ Price : $8.95]

A recent FDA pre-license inspection of Capricor Therapeutics San Diego manufacturing facility for investigation cell therapy Deram...

FDA Approves UroGen Bladder Cancer Therapy

[ Price : $8.95]

FDA approves a UroGen Pharma NDA for Zusduri (mitomycin intravesical solution) for adult patients with recurrent low-grade interme...

Viz.ai Subdural Hemorrhage Quantifier Cleared

[ Price : $8.95]

FDA clears a Viz.ai 510(k) for the Viz Subdural Plus, which the company describes as the first and only comprehensive solution for...